08/09/2018 17:34:06

STOCKHOLDER ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against National Beverage Corp. and Encourages Investors to Contact the Firm

RADNOR, Pa., Sept. 08, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against National Beverage Corp. (NASDAQ: FIZZ) (“National Beverage” or the “Company”) on behalf of purchasers of the Company’s securities between July 17, 2014 and July 3, 2018, inclusive (the “Class Period”).


  Investors who purchased National Beverage’s securities during the Class Period may, no later than September 17, 2018, seek to be appointed as a lead plaintiff representative of the class. 

National Beverage investors who seek to take a proactive role in the litigation – including current holders of the Company’s stock – are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740 or skaskela@kaskelalaw.com for additional information.  Investors may also register their information with the firm online at https://kaskelalaw.com/case/national-beverage-corp/,

On June 26, 2018, The Wall Street Journal published an article entitled “The SEC Has Had Its Own Questions About LaCroix,” which reported that National Beverage had “declined to provide,” in response to an SEC request, “requested figures to clarify sales claims.”   On this news, National Beverage’s share price fell $9.75, or 8.87%, to close at $100.19 on June 27, 2018.

Then, on July 3, 2018, The Wall Street Journal published an article entitled “Billionaire Behind LaCroix Accused of Improper Touching by Two Pilots.”  That article reported that “[t]wo pilots have filed lawsuits alleging sexual harassment . . . claiming 82-year-old Nick A. Caporella inappropriately touched them on multiple trips while they were flying with him in the cockpit of his business jet,” and that “[t]he suits claim the unwanted touching occurred on more than 30 trips from 2014 to 2016.” 

The shareholder class action complaint alleges that defendants made false and misleading statements during the Class Period and failed to disclose to investors that: (i) National Beverage’s sales claims and its supposed underlying “proprietary techniques” lacked a verifiable basis; (ii) National Beverage’s Chairman and Chief Executive Officer, Nick A. Caporella, engaged in a pattern of sexual misconduct between 2014 and 2016; and (iii) therefore, National Beverage’s public statements were materially false and misleading at all relevant times.  The complaint further alleges that, as a result of the foregoing, investors purchased National Beverage’s securities at artificially inflated prices during the Class Period, and have sustained significant investment losses as a result of defendants’ conduct.

National Beverage investors who seek to take a proactive role in the litigation – including current holders of the Company’s stock – are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740 or skaskela@kaskelalaw.com, or online at https://kaskelalaw.com/case/national-beverage-corp/, for additional information. 

Kaskela Law LLC exclusively represents investors in state and federal courts throughout the country.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.



D. Seamus Kaskela, Esq.

201 King of Prussia Road

Suite 650

Radnor, PA 19087

(484) 258 – 1585

(888) 715 – 1740




Related content
12 Jun - 
12 Jun - 
Bragar Eagel & Squire, P.C. is Investigating National B..
22 Feb - 
Research Report Identifies Raytheon, ConforMIS, Extreme..

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg


EuroInvestor: In Focus


EuroInvestor: In Focus


EuroInvestor: In Focus

Most read news

  • 24 hours
  • 48 hours
  • 1 week
SolarWinds New APAC Research Shows Insider Threats Rank as Top Cybersecurity Threat Concern
ROSEN, A TOP RANKED LAW FIRM, Reminds RCI Hospitality Holdings, Inc. Investors of July 22nd Deadline in Securities Class Action – RICK
Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
ROSEN, A TOP RANKED LAW FIRM, Reminds Community Health Systems, Inc. Investors of Important July 29th Deadline in the Securities Class Action– CYH
Black Creek Group Industrial Real Estate Investment Platform to be acquired by Prologis for $3.99 Billion

Related stock quotes

National Beverage Corp 41.86 -0.7% Stock price decreasing

Latest news

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
16 July 2019 09:57:08
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB2 - 2019-07-16 10:57:08 - 2019-07-16 09:57:08 - 1000 - Website: OKAY